Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Group B Streptococcus capsular polysaccharide serotype III is a sialylated repeating unit polysaccharide composed of glucose, galactose, N-acetylglucosamine, and sialic acid, featuring a disaccharide backbone with a branched trisaccharide side chain linked β-(1→4) to the backbone and terminating in α-(2→3)-linked sialic acid; it serves as a key surface antigen and virulence factor enabling immune evasion through antiphagocytic activity, with structural similarity to other GBS serotypes but distinct glycosidic linkages (e.g., β-D-GlcNAc-(1→6) between repeating units).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Group B Streptococcus capsular polysaccharide serotype III (GBS CPS type III).